Virtual Reality in End Stage Kidney Disease

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pennsylvania
Study ID
NCT06356168
Status
Recruiting

Conditions

  • End Stage Kidney Disease

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Social Virtual Reality — BEHAVIORAL
    Participants interact using virtual reality during dialysis.
  • Individual Virtual Reality — BEHAVIORAL
    Participants use virtual reality alone during dialysis.

Study Details

The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.

Key Dates

Start date
Mar 30, 2026
Status verified
Mar 2026
Primary completion
May 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Social Virtual Reality
    Social Virtual Reality will be delivered using virtual reality glasses for 30-45 minutes during dialysis sessions. Groups of 3 participants will watch a movie or program together through the glasses. They will be able to talk and interact during the session.
  • Active Comparator: Individual Virtual Reality
    Individual Virtual Reality will be delivered using virtual reality glasses for 30-45 minutes during dialysis sessions. Those randomized to this arm will watch a movie or program alone through the glasses.

Primary Outcome Measure

De Jong Gierveld Scale [ Time Frame: Baseline and 4 Weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of PennsylvaniaPhiladelphiaPennsylvania19104
Lea Ann Matura
713-410-1325

Find similar trials in Philadelphia, PA

Related Studies